Already a print subscriber?
Already a digital subscriber?
Never Miss a Story
Activate Print Subscription
Manage My Account
Celebs & Gossip
Things to Do
Home & Design
Sex & Dating
Find a Home
Print Offers Online
Daily News logo
PhillyPharma Archive: February, 2013
Follow Philly.com PhillyPharma :
Health & Pharma
Medicines Patent Pool gets help on HIV/AIDS drug from Glaxo-Pfizer-Shionogi joint venture
Thu, Feb 28, 2013, 7:04 AM
The Medicines Patent Pool, a public health-business collaborative formed to help beat disease in the developing world, announced a new deal...
FDA sends warning letter to Philly dye company, Abbey Color, about water problems in drug products
Wed, Feb 27, 2013, 11:47 AM
Abbey Color, Inc., an industrial dye manufacturer in the Kensington section of Philadelphia, was sent a warning letter by the U.S. Food and...
FDA does not anticipate furloughs if automatic budget cuts hit
Wed, Feb 27, 2013, 6:52 AM
If automatic federal budget cuts kick in Friday, patients, pharmaceutical companies — and the authorities paid to protect the first group...
NJ jury awards woman $3.35 million in first J&J vaginal mesh verdict
Tue, Feb 26, 2013, 6:51 AM
An Atlantic City jury awarded a former nurse $3.35 million for what the woman said were years of severe and chronic pain despite 18 unsuccessful...
Endo Health Solutions' new CEO is Rajiv De Silva
Mon, Feb 25, 2013, 10:06 AM
Endo Health Solutions, Inc., now has a new chief executive officer to go along with a new headquarters in Malvern, as the board of directors...
Singapore is a pharmaceutical hub, so now it aims for outer space
Mon, Feb 25, 2013, 6:44 AM
Singapore is not a big country, by land area, but years ago it became a big part of the global pharmaceutical world. Now it wants to send a...
High-priced drug for extreme cholesterol leaves insurers wary
Fri, Feb 22, 2013, 6:40 AM
The FDA's December approval of lomitapide (brand-name Juxtapid) to treat extremely high cholesterol will give patients a once-a-day capsule...
$78 million golden parachute for Novartis' Daniel Vasella
Mon, Feb 18, 2013, 7:08 AM
Novartis will pay Chairman Daniel Vasella $78 million when he departs the Swiss drugmaker, the Wall Street Journal reported over the weekend...
David Sell is a sports web producer. In previous lives, he has been a reporter and editor in the Sports, Metro and Business sections.